2.1 Overview of needle and syringe programsNeedle and Syringe Programs have been an important part of Australia's HIV/AIDS and Hepatitis C Strategies. NSPs are a public health measure funded to reduce the spread of blood borne viral infections such as HIV and hepatitis C among injecting drug users and are supported by the National Drug Strategy's harm reduction framework. They provide a range of services that include provision of injecting equipment and disposal facilities, education and information on reducing drug-related harms, referral to drug treatment, medical care and legal and other social services. Equipment provided includes needles and syringes, swabs, vials of sterile water and 'sharps bins' for the safe disposal of used injection equipment. The aim of providing sterile injecting equipment is to prevent the shared use of injecting equipment, which can lead to the transmission of blood borne viral infections. Staff also address the potential for transmission of infection via sexual contact by providing condoms and safer sex education. By engaging injecting drug users in health services, those who continue to use drugs are likely to incur less harm to themselves and society. NSPs are also an important point for collection of used injecting equipment.
There are different models of Needle and Syringe Programs operating in Australia and, depending on the jurisdiction, the proportions of these that are government run and non-government run vary. Furthermore, of the NSPs operating in the non-government sector, a number of these are 'peer-based' NSPs. Peer-based NSPs can be distinguished by the employment of past or current drug users in the development and provision of NSP services. It is widely understood that peer-based services have had a significant and positive impact on the delivery and acceptability of NSPs to injecting drug users.
Broadly, the following NSP service models exist throughout Australia:
- Primary outlets are stand-alone agencies that are specifically established to provide injecting equipment, sometimes along with primary medical care. Staff provide these specific services in a non-judgmental manner and develop a rapport with individuals who are otherwise hard to reach.
- Secondary outlets offer needle distribution or exchange as one of a range of other health or community services. Typical secondary outlets include hospital Accident and Emergency Departments and Community Health Centres.
- Mobile services are distribution and exchange services provided by vehicle or on foot. Top of page
- Outreach services have workers who move around from place to place to extend the reach of the service, often out of hours.
- Vending machines dispense needle and syringe packs containing several 1ml syringes for a small fee. These machines are monitored and restocked by Needle and Syringe Program staff.
Over 40 countries operate Needle and Syringe Programs including: Australia, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, India, Kazakhstan, Latvia, Luxembourg, Nepal, Netherlands, Norway, Philippines, Poland, Portugal, Slovak Republic, Salvador, Slovenia, Thailand, Ukraine, United Kingdom and the United States of America.
2.2 Operations of needle and syringe programsWhile Needle and Syringe Programs operate in all Australian States and Territories, their type, level of activity and funding arrangements differ considerably between jurisdictions. As part of this study, State and Territory health authorities provided details of the level of government expenditure and consumer fees paid for NSP services in recent years, together with estimates of the number of needles and syringes distributed. A summary of the data reported is presented in Table 2.1. It should be noted that in several instances, estimates have been imputed based on data provided by health authorities and the analysis of trends within each State/Territory.
The information presented in the table excludes expenditure on, and needles and syringes sold through pharmacies that sell these products on a commercial basis and are separate from government-auspiced NSPs. Reliable data on these services are not available across all jurisdictions, and consequently they have been excluded from the analysis presented in this report. However, in order to test the possible effect of their inclusion in the financial analysis, sensitivity analysis presented later in this report considers the impact of higher levels of costs of operating NSPs without any increase in benefit.
Table 2.1 Expenditure and needles distributed by NSPs by State/Territory, 1999/2000 (1)
1 Data relates to government-auspiced NSPs only. Excludes expenditure on needle and syringes sold through pharmacies on a commercial basis.
2 Includes figures imputed from data provided by State/Territory health authorities.